Reaction

Life Cycle Analysis Confirms Environmental Superiority of CoalSwitch® Reduces CO2 Emissions by 99% Relative to Coal and 97% Relative to Natural Gas

Retrieved on: 
Tuesday, June 28, 2022
GHG, AIM, Wood, COC, Transport, CEO, Reaction, Program, Technology, PacifiCorp, Coal, Chain of custody, GLOBE, Chalmers University of Technology, Greenhouse gas, Brigham Young University, CO2, STEP, Certification, University, Natural gas, FSC, Biomass, AEG, Renewable energy, Oil

The report was produced by Life Cycle Associates , an independent business and environmental consulting firm, based in California, specializing in life cycle analysis of fuel production pathways.

Key Points: 
  • The report was produced by Life Cycle Associates , an independent business and environmental consulting firm, based in California, specializing in life cycle analysis of fuel production pathways.
  • This Life Cycle Associates analysis provides significant independent confirmation of the reduced greenhouse gas emissions incurred in the production of CoalSwitch, said Michael Rowan, CEO of Active Energy Group.
  • These conclusions provide much needed data to prospective customers of CoalSwitch who have asked for this information from AEG in recent months.
  • We can now confirm CoalSwitch is not only sustainably sourced, but also provides significant performance improvements in greenhouse gas emissions as compared to coal and natural gas.

Reaction Biology Announces Expansion of Executive Leadership Team with Key Appointments in Commercial and Human Resources Functions

Retrieved on: 
Monday, May 16, 2022
People, List of professional associations in the United Kingdom, Senior, Corporate development, MBA, Roger W. Jones Award for Executive Leadership, Company, Pharmacology, Metropolitan, University of Strathclyde, Chicken as biological research model, Leadership, AstraZeneca, Patient, The Chartered Institute of Marketing, CCO, Executive Committee, Shire (pharmaceutical company), Therapy, La Salle University, Marketing, Metropolitan State University of Denver, BS, United Kingdom, Johnson & Johnson, WIL Research Laboratories, CPO, S-1 Executive Committee, Industry, Partnership, CRO, University, Organization, Corporation, Discovery, Charles River Laboratories, Human resources, Acquisition, Human, Drug discovery, Growth, Cancer, Management, Pharmaceutical industry, Fine chemical, Ethicon Inc., Chemistry, Reaction

MALVERN, Pa., May 16, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the expansion of its Executive Leadership team with the appointments of Alan Findlater to the position of Chief Commercial Officer (CCO) and Emily Doyle to the position of Chief People Officer (CPO). Mr. Findlater and Ms. Doyle will also serve as members of the Executive Committee, effective immediately. These new appointments strengthen Reaction's commercial and human resources functional areas.

Key Points: 
  • These new appointments strengthen Reaction's commercial and human resources functional areas.
  • "On behalf of the Executive Committee, we are incredibly pleased to welcome Alan and Emily to the Reaction Biology executive leadership team.
  • "Reaction Biology is at an important phase of its growth and evolution as a discovery partner of choice," said Alan Findlater, Chief Commercial Officer of Reaction Biology.
  • Emily Doyle brings more than 20 years of human resources, organizational development, and talent acquisition in the biopharmaceutical industry to Reaction.

New Data at AACR Showcase Reaction Biology's Innovative Approach to Oncology Drug Discovery Services

Retrieved on: 
Friday, April 8, 2022
Surface plasmon resonance, Company, Section 23, AM, Syngenic, Central Waqf Council, PM, 2D, Section 27 of the Canadian Charter of Rights and Freedoms, Systems biology, 3D, Section 40 of the Constitution of Australia, Section 39 of the Constitution of Australia, Comparison, PCR, Section 4, KRAS, AACR, Reaction, American Association, Neoplasm, 2021 Essex County Council election, Section 8, Association, American Association for Cancer Research, Section 24 of the Constitution of Australia, CDK, CRO, Section 11 of the Canadian Charter of Rights and Freedoms, Drug discovery, LRRK2, Section 5, Protein kinase, Pharmaceutical industry, Powder metallurgy, Electric motor, Online gambling

MALVERN, Pa., April 8, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced that twelve abstracts highlighting data from the Company's oncology drug discovery services platform will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13, 2022, in New Orleans, Louisiana.

Key Points: 
  • "At AACR 2022, we look forward to showcasing data from our comprehensive suite of innovative drug discovery services that continue to support our clients in their oncology research goals," said Haiching Ma, Ph.D., Chief Scientific Officer of Reaction Biology.
  • "With these data, we continue to build upon our capabilities as a world leader and partner in drug discovery."
  • Reaction will present data from a number of new and enhanced assays and other drug discovery services in oncology.
  • "These data at AACR represent the breadth and depth of Reaction Biology's pre-clinical research services in oncology and underscore why we are a preferred global partner in the area of drug discovery."

Reaction Biology Announces Appointment of Richard S. Kollender to Chief Financial Officer and Chief Business Officer

Retrieved on: 
Monday, April 4, 2022
Adoption, Company, Bedford Stuyvesant Restoration Corporation, Organization, GSK, Partner, NASDAQ, Marketing, Chicago (franchise), Marshall College, Growth, CBO, Board, LP, CFO, Reaction, GlaxoSmithKline, KPMG, Rich, Insming, MBA, CRO, Lehigh University, Drug discovery, Policy, Certified Public Accountant, Executive Committee, University, S-1 Executive Committee, Management, Fine chemical

"We are thrilled to welcome Rich, a seasoned healthcare finance and operations executive, to the Executive Committee of Reaction Biology," said John H. Johnson, Chief Executive Officer and Director of Reaction Biology.

Key Points: 
  • "We are thrilled to welcome Rich, a seasoned healthcare finance and operations executive, to the Executive Committee of Reaction Biology," said John H. Johnson, Chief Executive Officer and Director of Reaction Biology.
  • Prior to joining Reaction Biology, he served as Strongbridge BioPharma's President and Chief Financial Officer and was responsible for strengthening the company's financial position and footprint as a successful rare disease organization until it was acquired by Xeris Biopharma, Inc., in October 2021.
  • In addition, from August 2016 through September 2018, he served as Chief Business Officer and Chief Financial Officer of Rapid Micro Biosystems, a Quaker Partners' portfolio company, where he played a key role in the business expansion and adoption of the company's Growth Direct System.
  • "Reaction Biology is entering a pivotal phase in its development as a preferred partner to biopharmaceutical companies in the exciting and ever-changing area of drug discovery," said Richard S. Kollender.

Sodexo Campus Innovation Takes Major Leap Forward with Eat NOW Autonomous Grocery Stores Powered by AiFi, Ramen-Making Robots, Mariah Carey’s Cookies, and MrBeast Burger

Retrieved on: 
Monday, March 28, 2022
Mithril, LinkedIn, Partnership, Express, Group, Health, New Mexico State University, Compass Group, AiFi, University, Verizon Communications, MrBeast Burger, Entrepreneurship, Government, Quality of life, Technology, Safety, Twitter, Gonzaga University, Qualcomm Ventures, GLOBE, Foodservice, Student, REWE, Solution, YouTube, Education, Instagram, Evolution, Volunteering, Collection, Algorithm, Food delivery, Management, Online shopping, Fast food, Sodexo, Reaction, Morrisons, Facebook

In partnership with AiFi, the most flexible AI platform enabling autonomous shopping solutions, Sodexo introduces eat>NOW, a frictionless, checkout-free grocery and convenience offer.

Key Points: 
  • In partnership with AiFi, the most flexible AI platform enabling autonomous shopping solutions, Sodexo introduces eat>NOW, a frictionless, checkout-free grocery and convenience offer.
  • Were proud to partner with Sodexo, a leader in innovating campus foodservice, said Steve Gu, AiFis CEO and co-founder.
  • This partnership allows AiFi to bring our leading technology to campuses across the country with a proven leader in food services.
  • Virtual Dining Concepts is a collection of concepts such as MrBeast Burger, Mariahs Cookies, and Buddy Vs Cake Slice.

Reaction Biology Launches InVEST Screening Panel to Identify Drug Toxicity Effects of New Drug Candidates

Retrieved on: 
Tuesday, March 22, 2022
Company, Human, Pharmacology, Ion, Research, Reaction, Pressure, CRO, Drug discovery, Toxication, Enzyme, Disulfiram-like drug, Patient, Investment, Pharmaceutical industry, Safety, Toxicity

MALVERN, Pa., March 22, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the launch of its In Vitro Evaluation of Safety and Toxicity (InVEST) Panel, an early safety pharmacology tool that detects potential drug toxicity effects that may cause adverse drug reactions and hinder clinical development. The new group of assays adds to the more than 2,000 biochemical, cell-based, biophysical, and in vivo assays in the Reaction Biology drug discovery portfolio.

Key Points: 
  • The new group of assays adds to the more than 2,000 biochemical, cell-based, biophysical, and in vivo assays in the Reaction Biology drug discovery portfolio.
  • "The InVEST panel is a significant addition to our expanding portfolio of end-to-end solutions supporting the discovery of new drug candidates from target research through preclinical candidate selection," said Haiching Ma, Ph.D., Chief Scientific Officer of Reaction Biology.
  • "Safety pharmacology screening against our InVEST panel will enable our clients to detect potential toxicity issues and optimize targets, ultimately improving success rates in clinical trials and with regulatory submissions."
  • Early safety profiling with the InVEST panel includes 35 clinically relevant targets of six target families for broad coverage of potential adverse drug effects.

Reaction Biology Announces Closing of Growth Investment from Cobepa and Chief Executive Officer Transition

Retrieved on: 
Wednesday, March 16, 2022
CRO, 2009 Davis Cup, Acquisition, Drug discovery, VSTM, Board of directors, Partnership, Investment, Golub Capital, Verastem Oncology, ImClone Systems, Science, Johnson & Johnson, Cinven, Oncology, Principal, Board, Company, Leadership, CEO, Growth, LLP, Industry, Immunology, White & Case, Reaction Design, Pharmaceutical industry, Management, Fine chemical, Financial services, Biopharmaceutical, Director, Reaction

MALVERN, Pa., March 16, 2022 /PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced the closing of a significant investment from Cobepa, an international private equity firm, to fuel the Company's continued growth and service line expansion.

Key Points: 
  • The Company also announced the appointment of John H. Johnson to Chief Executive Officer (CEO) and Board Director of Reaction Biology, effective immediately.
  • "Reaction Biology has a decades-long history of delivering excellent science and driving customer-centric innovation," said Peter Connolly, Managing Director and Head of Cobepa North America.
  • "We are thrilled to partner with John and the team at Reaction Biology for the Company's next phase of evolution."
  • William Blair & Co. acted as exclusive financial advisor to Reaction Biology, and Piper Sandler acted as exclusive financial advisor to Cobepa.

AEG Achieves FSC Certification for CoalSwitch™ Production

Retrieved on: 
Tuesday, March 15, 2022
Sulfur dioxide, COC, PacifiCorp, Program, Biophysical environment, FSC, University, Brigham Young University, GLOBE, Certification, Chalmers University of Technology, AIM, Social Security Government Pension Offset, Forest Stewardship Council, AEG, Burns, Â, Biomass, ESG, Company, Forest, CEO, Contract, Chain of custody, Coal, Social, Reaction, Technology, STEP, Tissue paper, Renewable energy

The process of attaining this FSC certification has included rigorous audits by the independent accredited certification body SCS Global Services.

Key Points: 
  • The process of attaining this FSC certification has included rigorous audits by the independent accredited certification body SCS Global Services.
  • These audits examine the full CoalSwitch production process, encompassing the entire supply chain from feedstock source to final production of fuel.
  • Active Energys certification to these FSC standards confirms that the production of CoalSwitch will use forest-based materials from responsible sources and that the Companys suppliers have committed to the strictest standards currently governing forest management.
  • FSC chain of custody certification provides a credible assurance that products which are sold with an FSC claim originate from well-managed forests, controlled sources, or reclaimed materials.

AiFi Raises $65 Million in Series B Funding to Strengthen Leadership Position in Autonomous Retail

Retrieved on: 
Friday, March 11, 2022
Mithril, Time, MEC, Qualcomm, Verizon Communications, Compass Group, Nano, AiFi, NFL, REWE, News, Multimedia, Qualcomm Ventures, ALDI, Evolution, Solution, Technology, University, Flash, Intelligence, Algorithm, Carrefour City, View, Renewable energy, Retail, Online shopping, Video game, Reaction, Morrisons

The strategic investments from our retail partners reflect a commitment to scale with AiFi after successful platform integrations and positive customer feedback.

Key Points: 
  • The strategic investments from our retail partners reflect a commitment to scale with AiFi after successful platform integrations and positive customer feedback.
  • It's become clear that shoppers are ready for autonomous retail and AiFi is here to deliver," says Steve Gu, AiFi CEO and co-founder.
  • We have deepened our partnerships with some of the world's largest retailers that share a vision of innovation.
  • AiFi provides the most flexible AI platform that enables retailers to affordably deploy and scale autonomous shopping solutions across their businesses.

AiFi Raises $65 Million in Series B Funding to Strengthen Leadership Position in Autonomous Retail

Retrieved on: 
Friday, March 11, 2022
Mithril, Time, MEC, Qualcomm, Verizon Communications, Compass Group, Nano, AiFi, NFL, REWE, News, Qualcomm Ventures, ALDI, Evolution, Solution, Technology, University, Flash, Intelligence, Algorithm, Carrefour City, Renewable energy, Retail, Online shopping, Reaction, Morrisons

SANTA CLARA, Calif., March 11, 2022 /PRNewswire/ -- AiFi, the most flexible AI platform that enables retailers to affordably deploy and scale autonomous shopping solutions, today announced a $65 million Series B funding round with participation from ALDI South Group, Żabka Group, REWE, Verizon Ventures, and Qualcomm Ventures LLC, among others. The strategic investments from our retail partners reflect a commitment to scale with AiFi after successful platform integrations and positive customer feedback. This round, which brings AiFi's total funding to $80 million, will primarily be used to expand the company's technical team to cater to the surging demand for AiFi's solution.

Key Points: 
  • The strategic investments from our retail partners reflect a commitment to scale with AiFi after successful platform integrations and positive customer feedback.
  • It's become clear that shoppers are ready for autonomous retail and AiFi is here to deliver," says Steve Gu, AiFi CEO and co-founder.
  • AiFi provides the most flexible AI platform that enables retailers to affordably deploy and scale autonomous shopping solutions across their businesses.
  • AiFi has the highest number of computer vision powered autonomous stores across the globe.